Jordi Carratalà
ORCID: 0000-0003-3209-2563Also affiliated with Bellvitge University Hospital, Institut d'Investigació Biomédica de Bellvitge, Centro de Investigación Biomédica en Red, Universitat de Barcelona
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Why this DataRank?
An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.
Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.
Read the full methodology →Papers
Driven by 5 papers. Top paper: “Tocilizumab in patients hospitalised with COVID-19 pneumonia: Efficacy, safety, viral clearance, and antibody response from a randomised controlled trial (COVACTA)”.
Norbert Bräu, Michael R. Waters, Ronaldo C. Go, Atul Malhotra, Bradley D. Hunter +32 more
José-María Miró, Evelyn Shaw, Jose-María Aguado, Rafael San-Juan, Mireia Puig-Asensio +48 more
Adaia Albasanz‐Puig, Ana Fernández‐Cruz, Marina Machado, Andrés Novo, David van Duin +29 more
Zsuzsa Bakk, Annette C. Westgeest, Karla Berry, George Cooper, Wynne Sim +19 more
Álvarez-Uría A., del Pozo J.L., Natàlia Pallarés, Jordi Carratalà, Nadia Castaldo +30 more